Clinical trials sponsored by TG Therapeutics, Inc.

Phase breakdown

Conditions studied

Recruiting trials led by TG Therapeutics, Inc.

• A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
  NCT06433765 · Phase: Not specified · Ages: 15 Years to 50 Years · Sex: Female · 1 location
• A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
  NCT06143514 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 5 locations
• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 109 locations
• A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
  NCT06680037 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
  NCT07503873 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 39 locations
• Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
  NCT07220252 · Phase: Phase 2, Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
  NCT05877963 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 51 locations
• Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
  NCT07680946 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is TG Therapeutics, Inc. recruiting for?

TG Therapeutics, Inc. is the lead sponsor of 8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.